Synapses are highly specialized intercellular junctions organized by adhesive and scaffolding molecules that align presynaptic vesicular release with postsynaptic neurotransmitter receptors. The MALS/Veli–CASK–Mint-1 complex of PDZ proteins occurs on both sides of the synapse and has the potential to link transsynaptic adhesion molecules to the cytoskeleton. In this study, we purified the MALS protein complex from brain and found liprin-α as a major component. Liprin proteins organize the presynaptic active zone and regulate neurotransmitter release. Fittingly, mutant mice lacking all three MALS isoforms died perinatally with difficulty breathing and impaired excitatory synaptic transmission. Excitatory postsynaptic currents were dramatically reduced in autaptic cultures from MALS triple knockout mice due to a presynaptic deficit in vesicle cycling. These findings are consistent with a model whereby the MALS–CASK–liprin-α complex recruits components of the synaptic release machinery to adhesive proteins of the active zone.
Skip Nav Destination
Article navigation
26 September 2005
Article|
September 26 2005
Neurotransmitter release regulated by a MALS–liprin-α presynaptic complex
Olav Olsen,
Olav Olsen
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Kimberly A. Moore,
Kimberly A. Moore
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Masaki Fukata,
Masaki Fukata
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Toshinari Kazuta,
Toshinari Kazuta
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Jonathan C. Trinidad,
Jonathan C. Trinidad
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Fred W. Kauer,
Fred W. Kauer
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Michel Streuli,
Michel Streuli
4ImmunoGen, Inc., Cambridge, MA 02139
Search for other works by this author on:
Hidemi Misawa,
Hidemi Misawa
5Department of Neurology, Metropolitan Institute for Neuroscience, Tokyo 183-8526, Japan
Search for other works by this author on:
Alma L. Burlingame,
Alma L. Burlingame
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Roger A. Nicoll,
Roger A. Nicoll
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
David S. Bredt
David S. Bredt
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Olav Olsen
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Kimberly A. Moore
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143
Masaki Fukata
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Toshinari Kazuta
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Jonathan C. Trinidad
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143
Fred W. Kauer
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Michel Streuli
4ImmunoGen, Inc., Cambridge, MA 02139
Hidemi Misawa
5Department of Neurology, Metropolitan Institute for Neuroscience, Tokyo 183-8526, Japan
Alma L. Burlingame
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143
Roger A. Nicoll
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143
David S. Bredt
1Department of Physiology, University of California, San Francisco, San Francisco, CA 94143
Correspondence to David S. Bredt: [email protected]
Abbreviations used in this paper: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; CaMK, CAM kinase; DIV, days in vitro; EPSC, excitatory postsynaptic current; MS, mass spectrometry; NMDA, N-methyl-d-aspartate; PSD, postsynaptic density; SAM, sterile α motif; TKO, triple knockout; WT, wild type.
Received:
March 03 2005
Accepted:
August 22 2005
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2005
J Cell Biol (2005) 170 (7): 1127–1134.
Article history
Received:
March 03 2005
Accepted:
August 22 2005
Citation
Olav Olsen, Kimberly A. Moore, Masaki Fukata, Toshinari Kazuta, Jonathan C. Trinidad, Fred W. Kauer, Michel Streuli, Hidemi Misawa, Alma L. Burlingame, Roger A. Nicoll, David S. Bredt; Neurotransmitter release regulated by a MALS–liprin-α presynaptic complex . J Cell Biol 26 September 2005; 170 (7): 1127–1134. doi: https://doi.org/10.1083/jcb.200503011
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement